HIV阳性头颈鳞癌患者的预后生物标志物研究
该研究利用组织微阵列和免疫组化,比较41例HIV阳性与44例HIV阴性头颈鳞癌患者的肿瘤生物标志物表达。结果显示标志物表达不受HIV状态影响;在HIV阳性患者中,喉部原发部位和CD4<200 cells/μL与预后不良相关,p16阳性与总生存改善相关,TGF-β高表达与不良临床结局相关。
要点
- HIV状态不影响头颈鳞癌肿瘤生物标志物的表达水平。
- HIV阳性患者中,喉部原发部位和CD4<200 cells/μL提示预后不良。
- p16阳性与总生存改善相关,TGF-β高表达与不良结局相关。
核心结论
- 疾病原发部位对生物标志物表达有显著影响。
- 肿瘤TGF-β表达可能作为传统风险分层的有价值补充,以改善头颈癌疾病管理策略。
研究设计与样本
- 构建组织微阵列,纳入41例HIV阳性头颈鳞癌病例和44例HIV阴性头颈鳞癌对照,按疾病部位和年龄匹配。
- 通过免疫组化评估肿瘤生物标志物表达,并与临床变量进行相关性分析。
主要发现
- 所研究的致癌和炎症肿瘤生物标志物表达水平未因HIV状态而存在差异调控。
- 在HIV阳性头颈鳞癌患者中,喉部疾病部位(P = .003)和Clavien-Dindo IV级(CD4)计数<200 cells/μL(P = .01)与不良预后相关。
- 多因素分析显示p16阳性与总生存改善相关(P < .001),而转化生长因子-β(TGF-β)表达增加与不良临床结局相关(P = .001)。
临床怎么用
- 对于HIV阳性头颈鳞癌患者,可结合喉部原发部位和CD4<200 cells/μL识别高危人群。
- 检测p16和TGF-β表达可能有助于预后分层,TGF-β可作为传统风险分层的补充指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We examined the prognostic value of a panel of biomarkers in patients with squamous cell carcinoma of the head and neck (SCCHN) who were human immunodeficiency virus (HIV) positive (HIV-positive head and neck cancer) and HIV negative (HIV-negative head and neck cancer). METHODS: Tissue microarrays (TMAs) were constructed using tumors from 41 disease site-matched and age-matched HIV-positive head and neck cancer cases and 44 HIV-negative head and neck cancer controls. Expression of tumor biomarkers was assessed by immunohistochemistry (IHC) and correlations examined with clinical variables. RESULTS: Expression levels of the studied oncogenic and inflammatory tumor biomarkers were not differentially regulated by HIV status. Among patients with HIV-positive head and neck cancer, laryngeal disease site (P = .003) and Clavien-Dindo classification IV (CD4) counts <200 cells/μL (P = .01) were associated with poor prognosis. Multivariate analysis showed that p16 positivity was associated with improved overall survival (OS; P < .001) whereas increased expression of transforming growth factor-beta (TGF-β) was associated with poor clinical outcome (P = .001). CONCLUSION: Disease site has significant effect on the expression of biomarkers. Expression of tumor TGF-β could be a valuable addition to the conventional risk stratification equation for improving head and neck cancer disease management strategies.
引用
- Zhang H, Kim S, Chen Z, et al. Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma. Head Neck. 2017. PMID: 28945296. doi:10.1002/hed.24911
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。